Bombesin administration impairs memory and does not reverse memory deficit caused by sleep deprivation
L B T Ferreira1, S L B Oliveira1, J Raya1
1Psychobiology Department, Universidade Federal de São Paulo, São Paulo, Brazil.
Behavioural Brain Research
|May 17, 2017
Summary
Sleep deprivation impairs memory. Bombesin (a GRP agonist) did not prevent this impairment in rats and actually hindered memory consolidation under normal conditions, suggesting it
Area of Science:
- Neuroscience
- Behavioral Neuroscience
- Pharmacology
Background:
- Sleep deprivation negatively impacts emotional memory performance.
- Neuropeptides like Gastrin Releasing Peptide (GRP) may regulate memory processes.
- GRP's role in sleep deprivation-induced memory deficits requires further investigation.
Purpose of the Study:
- To investigate the effect of Bombesin (BB), a GRP agonist, on memory performance in sleep-deprived Wistar rats.
- To determine if BB administration can mitigate memory impairments caused by sleep loss.
- To assess BB's impact on memory consolidation under normal sleep conditions.
Main Methods:
- Wistar rats were subjected to sleep deprivation using the modified multiple platforms method (MMPM).
- Intraperitoneal (IP) administration of varying doses of BB (2.5, 5.0, 10.0μg/kg) was performed.
- Memory performance was evaluated using a multiple trial inhibitory avoidance (MTIA) task, assessing acquisition and retention.
Main Results:
- Sleep-deprived rats showed significant impairment in both memory acquisition and retention.
- BB administration failed to prevent or ameliorate the memory deficits induced by sleep deprivation.
- In non-sleep-deprived rats, BB administration before and after training, but not before testing, resulted in a retention deficit.
Conclusions:
- Bombesin (BB) does not counteract memory impairment caused by sleep deprivation.
- Under normal conditions, BB administration appears to impair memory consolidation.
- These findings suggest GRP modulation by BB is not a viable strategy to mitigate sleep deprivation-induced memory deficits.
Related Concept Videos
Management of Insomnia
744
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
744
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
751
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
751
Sedatives and Hypnotics Drugs: Miscellaneous Agents
706
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
706
Amnesia
663
Amnesia is a condition marked by long-term memory loss, which impairs the ability to recall past events or create new memories.
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
The severity and duration of memory loss vary depending on the type and underlying cause. Amnesia is classified into two main types: retrograde and anterograde.
Retrograde amnesia is marked by the loss of memories formed before the onset of the condition. Patients may recall distant past events but often forget those occurring shortly before the incident.
Anterograde...
663
Higher Mental Functions of Brain: Learning and Memory
2.2K
Memory is one of the most vital higher mental functions of the brain. Memory is closely related to learning because it enables us to retain information and experiences from our past to use them in our present life. It also helps us to remember facts, events, and skills, such as riding a bike or swimming. There are two types of memory — declarative memory, which involves memorizing facts or events, and procedural memory, which enables us to remember how to do something like writing or...
2.2K
CNS Depressants: Barbiturates and Benzodiazepines
1.5K
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
1.5K


